Loading...
Dernières publications
-
Dylan Moutachi, Janek Hyzewicz, Pauline Roy, Mégane Lemaitre, Damien Bachasson, et al.. Treadmill running and mechanical overloading improved the strength of the plantaris muscle in the dystrophin‐desmin double knockout (DKO) mouse. The Journal of Physiology, In press, ⟨10.1113/JP286425⟩. ⟨hal-04643936⟩
-
Medhi Hassani, Dylan Moutachi, Mégane Lemaitre, Alexis Boulinguiez, Denis Furling, et al.. Beneficial effects of resistance training on both mild and severe mouse dystrophic muscle function as a preclinical option for Duchenne muscular dystrophy. PLoS ONE, 2024, 19, ⟨10.1371/journal.pone.0295700⟩. ⟨hal-04501283⟩
-
Antonio Atalaia, Dagmar Wandrei, Nawel Lalout, Rachel Thompson, Adrian Tassoni, et al.. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders. Orphanet Journal of Rare Diseases, 2024, 19 (1), pp.66. ⟨10.1186/s13023-024-03059-3⟩. ⟨hal-04460667⟩
-
-
Florent Porquet, Lin Weidong, Kévin Jehasse, Hélène Gazon, Maria Kondili, et al.. Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells. Molecular Therapy - Nucleic Acids, 2023, 32, pp.857 - 871. ⟨10.1016/j.omtn.2023.05.007⟩. ⟨hal-04287597⟩
-
Caroline Le Guiner, T Larcher, A Lafoux, G Toumaniantz, S Webb, et al.. Characterization of the muscular and cardiac diseases of the DMSXL mouse model, a transgenic mouse model for Myotonic Dystrophy type 1. American Society of Gene & Cell Therapy, May 2023, LOS ANGELES, United States. ⟨hal-04096181⟩
-
-
Dylan Moutachi, Mégane Lemaitre, Clément Delacroix, Onnik Agbulut, Denis Furling, et al.. Valproic acid reduces muscle susceptibility to contraction‐induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy. Clinical and Experimental Pharmacology and Physiology, In press, ⟨10.1111/1440-1681.13804⟩. ⟨hal-04146953⟩
-
-
Chiffres clés
135
Publications avec texte intégral
Open Access
53 %
Mots clés
Animals
Desmin
PCR
Dystrophie Myotonique
Myotonic Dystrophy Type 1
Transgenic mouse
Myostatin
Myotonic dystrophy
Maximal force
Central nervous system
Aging
Glucocorticoid-receptor
Brain dysfunction
Myotonic Dystrophy
Endurance training
Glucocorticoids
Antisense oligonucleotide
DM1
Exercice
PacBio
Mouse model
Cardiac muscle
BIOLOGIE MOLECULAIRE
Intermediate filament
Therapy
GABA
Antisense oligonucleotides
Trinucleotide Repeat Expansion
ARN
Transgenic mouse model
KNOCKOUT MICE
Male
CONGENITAL MYATHENIC SYNDROME
Centronuclear myopathy
Fibrosis
Expression
In vivo
Dystrophin
AAV
Duchenne muscular dystrophy
Gene therapy
Genotype phenotype correlation
Acetylcholinesterase deficiency
Cell model
Mice
Humans
Acute coronary syndrome
CMS
Cell culture model
Cytoskeleton
Knockout
Dystrophie myotonique
Thérapie génique
Acetylcholinesterase knockout mouse
Astrocyte
Myelin
Oligodendrocytes
CTG repeat contractions
Myotonic dystrophy type 1
Motoneuron
Quantitative microdialysis
CTG repeats
Mouse models
Myotonic dystrophy mouse models
Gene editing
Myotonic Dystrophy type 1
Cell penetrating peptide
Muscle
Transcriptomics
RNA splicing
Skeletal muscle
Exercise
DMPK
Heart failure
Long read sequencing
RNA interference
CRISPR/Cas9
Muscular dystrophy
Glutamate
CRISPRi
RNA biology
Brain
Dynamin 2
Oligodendrocyte
Alternative splicing
Glial cells
Neuron
GSK3
Astrocytes
ACETYLCHOLINESTERASE
MBNL
Trinucleotide repeat expansion
DMSXL mice
Hypoxia
Gene Therapy
Autophagy
Diaphragm
Heart
CTG repeat instability
Dilated cardiomyopathy